Janux Therapeutics, Inc 10-Q for FY2026 Q1
Janux Therapeutics, Inc. (JANX)
10-Q
2026-05-07
For: 2026-03-31
View Original
Added on
May 07, 2026
About this 10-Q
Janux Therapeutics, Inc filed this 10-Q on May 7, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.73M
- compared with $0 a year earlier
- Net loss
- $24.36M
- compared with a net loss of $23.51M a year earlier
- Diluted EPS
- -$0.39
- compared with -$0.38 a year earlier